Biocon Biologics insulin manufacturing facility in Malaysia completes USFDA (PAI) inspection
At the conclusion of the inspection, the agency has issued a form 483 with a total of 6 observations across drug substance, drug…
Recover your password.
A password will be e-mailed to you.